価格表
在庫・価格 ： 2025年07月04日 19時44分 現在
| 商品名 | 商品コード | メーカー | 包装 | 価格 | 在庫 | リスト |
|---|---|---|---|---|---|---|
|
Anti-HDAC3, Rabbit-Poly データシート |
NB100-1669 |
NOVノバス バイオロジカルス Novus biologicals, LLC |
0.1 mg | ¥96,000 |
無 (未発注) |
追加 |
在庫・価格 ： 2025年07月04日 19時44分 現在
使用文献
| No. | 文献情報 | 備考 | 参照 |
|---|---|---|---|
| 1 |
Imbriano C et al. Direct p53 transcriptional repression: in vivo analysis of CCAAT-containing G2/M promoters. Mol. Cell. Biol. 2005 May;25(9):3737-51 Imbriano C et al 2005/01/01 |
Applications: ChIP |  |
| 2 |
Wilson AJ et al. Histone deacetylase 3 (HDAC3) and other class I HDACs regulate colon cell maturation and p21 expression and are deregulated in human colon cancer. J. Biol. Chem. 2006 May;281(19):13548-58 Wilson AJ et al 2006/01/01 |
|
|
| 3 |
Caretti G et al. Dynamic recruitment of NF-Y and histone acetyltransferases on cell-cycle promoters. J. Biol. Chem. 2003 Aug;278(33):30435-40 Caretti G et al 2003/01/01 |
Applications: ChIP | |
| 4 |
Wilson AJ et al. HDAC4 promotes growth of colon cancer cells via repression of p21. Mol. Biol. Cell 2008 Oct;19(10):4062-75 Wilson AJ et al 2008/01/01 |
|
|
| 5 |
Mano T et al. Differential effect of HDAC3 on cytoplasmic and nuclear huntingtin aggregates. PLoS ONE 2014;9(11):e111277 Mano T et al 2014/01/01 |
Species: Human, Applications: WB, ICC/IF | |
| 6 |
Jiang C et al. A sequential treatment of depsipeptide followed by 5-azacytidine enhances Gadd45beta expression in hepatocellular carcinoma cells. Anticancer Res. ;27(6B):3783-9 Jiang C et al |
Species: Human, Applications: WB | |
| 7 |
Baek MH et al. Immunohistochemical Characterization of Histone Deacetylase as a Potential Prognostic Marker and Therapeutic Target in Endometrial Stromal Sarcoma. Anticancer Res. 2016 May;36(5):2527-34 Baek MH et al 2016/01/01 |
|
|
| 8 |
Wang J et al. Repression of the miR-627-5p by histone deacetylase 3 contributes to hypoxia-induced hepatocellular carcinoma progression. J Cancer 2021;12(17):5320-5330 Wang J et al 2021/01/01 |
Applications: ChIP | |
- No.： 1
-
文献情報：
Imbriano C et al. Direct p53 transcriptional repression: in vivo analysis of CCAAT-containing G2/M promoters. Mol. Cell. Biol. 2005 May;25(9):3737-51
Imbriano C et al
2005/01/01
-
備考：
Applications: ChIP -
参照：
- No.： 2
-
文献情報：
Wilson AJ et al. Histone deacetylase 3 (HDAC3) and other class I HDACs regulate colon cell maturation and p21 expression and are deregulated in human colon cancer. J. Biol. Chem. 2006 May;281(19):13548-58
Wilson AJ et al
2006/01/01
-
備考：
-
参照：
- No.： 3
-
文献情報：
Caretti G et al. Dynamic recruitment of NF-Y and histone acetyltransferases on cell-cycle promoters. J. Biol. Chem. 2003 Aug;278(33):30435-40
Caretti G et al
2003/01/01
-
備考：
Applications: ChIP -
参照：
- No.： 4
-
文献情報：
Wilson AJ et al. HDAC4 promotes growth of colon cancer cells via repression of p21. Mol. Biol. Cell 2008 Oct;19(10):4062-75
Wilson AJ et al
2008/01/01
-
備考：
-
参照：
- No.： 5
-
文献情報：
Mano T et al. Differential effect of HDAC3 on cytoplasmic and nuclear huntingtin aggregates. PLoS ONE 2014;9(11):e111277
Mano T et al
2014/01/01
-
備考：
Species: Human, Applications: WB, ICC/IF -
参照：
- No.： 6
-
文献情報：
Jiang C et al. A sequential treatment of depsipeptide followed by 5-azacytidine enhances Gadd45beta expression in hepatocellular carcinoma cells. Anticancer Res. ;27(6B):3783-9
Jiang C et al
-
備考：
Species: Human, Applications: WB -
参照：
- No.： 7
-
文献情報：
Baek MH et al. Immunohistochemical Characterization of Histone Deacetylase as a Potential Prognostic Marker and Therapeutic Target in Endometrial Stromal Sarcoma. Anticancer Res. 2016 May;36(5):2527-34
Baek MH et al
2016/01/01
-
備考：
-
参照：
- No.： 8
-
文献情報：
Wang J et al. Repression of the miR-627-5p by histone deacetylase 3 contributes to hypoxia-induced hepatocellular carcinoma progression. J Cancer 2021;12(17):5320-5330
Wang J et al
2021/01/01
-
備考：
Applications: ChIP -
参照：